SPY301.38-1.59 -0.52%
DIA252.31-2.04 -0.80%
IXIC9,371.13+2.14 0.02%

JP Morgan Maintains Underweight on AMAG Pharmaceuticals, Lowers Price Target to $8

JP Morgan maintains AMAG Pharmaceuticals (NASDAQ:AMAG) with a Underweight and lowers the price target from $9 to $8.

Benzinga · 05/12/2020 15:00

JP Morgan maintains AMAG Pharmaceuticals (NASDAQ:AMAG) with a Underweight and lowers the price target from $9 to $8.